Evidence map›Paper›PMID 36672750›Full record

ArticleGenes2022

Polymorphisms in

Firzana Firfirey, Delva Shamley, Alison V September

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Firzana FirfireyDivision of Physiological Sciences, Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Cape Town 7700, South Africa.ORCID 0000-0002-8750-1654
Delva ShamleyDivision of Clinical Anatomy & Biological Anthropology, Department of Human Biology, Anatomy Building, Medical School, University of Cape Town, Cape Town 7700, South Africa.ORCID 0000-0003-2355-6629
Alison V SeptemberDivision of Physiological Sciences, Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Cape Town 7700, South Africa.
University of Cape Town · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic shoulder pain and disability is a common adverse effect experienced by >40% of breast cancer survivors (BCS). Pain management protocols for acute and chronic pain include the use of opioids and opioid derivatives. Furthermore, pain-modulating genes, such as

Indexed as

Breast NeoplasmsCancer SurvivorsChronic PainAnalgesics, OpioidCatechol O-MethyltransferaseFemaleHumansReceptors, Opioid, muShoulder PainSouth AfricaAnalgesics, OpioidCatechol O-MethyltransferaseCOMT protein, humanOPRM1 protein, humanReceptors, Opioid, muBreast Cancer Survivors (BCS)chronic shoulder pain and disabilityGene-Gene interactionsgenetic association

Identifiers

PMID36672750
PMCPMC9858584
OpenAlexW4313472050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.